Is Geron Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Geron Corp (GERN) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Geron Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Geron Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Geron Corp?

Muslim investors may consider investing in Geron Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Geron Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Geron Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Geron Corp updated?

The Shariah compliance status of Geron Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Geron Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Geron Corp?

You can check the latest Shariah compliance status of Geron Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GERN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 04, 2026

Report Source: 2025 Annual Report

Geron Corp. Stock Analysis GERN

United States Health Care Small Cap Report: 2025 Annual

Geron Corp. operates as a biotechnology company. The company is headquartered in Foster City, California and currently employs 258 full-time employees. The firm develops first-in-class telomerase inhibitor, RYTELO (imetelstat) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (lower-risk MDS), with transfusion-dependent (TD) anemia requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESAs). RYTELO is supported by the high unmet need in lower-risk MDS, including the observed benefit of RYTELO in difficult-to-treat subpopulations, such as patients with high transfusion burden and ring sideroblast negative (RS-) patients. The company is also engaged in conducting a pivotal Phase III clinical trial of imetelstat in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF), as well as studies in other myeloid hematologic malignancies.

Key Statistics of Geron Corp (GERN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.29$1.40

Today's Open

$1.40

Volume

16.16M

P/E Ratio (TTM)

52 Week Range

$1.04$2.01

Market Cap

1.06B

Avg. Volume

16.48M

Dividend Yield

Financial Metrics & Statements of Geron Corp (GERN)

FAQ's for Geron Corp (GERN)

According to Musaffa’s Shariah screening methodology, Geron Corp (GERN) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.